Symbols / ENTA Stock $14.35 +3.31% Enanta Pharmaceuticals, Inc.

Healthcare • Biotechnology • United States • NMS
ENTA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index
Sector Healthcare
Industry Biotechnology
CEO
Exch · Country NMS · United States
Market Cap 403.08M
Enterprise Value
Income
Sales
FCF (ttm)
Book/sh
Cash/sh
Employees
Insider 10d
IPO
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout
P/E
Forward P/E
PEG
P/S
P/B
P/C
EV/EBITDA
EV/Sales
Quick Ratio
Current Ratio
Debt/Eq
LT Debt/Eq
EPS (ttm)
EPS next Y
EPS Growth
Revenue Growth
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next)
Earnings (prior)
ROA
ROE
ROIC
Gross Margin
Oper. Margin
Profit Margin
Shs Outstand
Shs Float
Insider Own
Instit Own
Short Float
Short Ratio
Short Interest
52W High
vs 52W High
52W Low
vs 52W Low
Beta
Impl. Vol.
Rel Volume
Avg Volume
Volume
Target (mean)
Tgt Median
Tgt Low
Tgt High
# Analysts
Recom
Prev Close $13.89
Price $14.35
Change 3.31%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified FCF or EPS-based estimate
Ratings
Current target
Low
High
Mean
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
65.32
-3.42%
67.64
-14.61%
79.20
-8.07%
86.16
Operating Revenue
65.32
-3.42%
67.64
-14.61%
79.20
-8.07%
86.16
Operating Expense
150.67
-20.42%
189.33
-12.52%
216.41
+3.05%
210.00
Research And Development
106.74
-18.81%
131.48
-19.60%
163.52
-0.61%
164.52
Selling General And Administration
43.93
-24.06%
57.85
+9.38%
52.89
+16.28%
45.48
General And Administrative Expense
43.93
-24.06%
57.85
+9.38%
52.89
+16.28%
45.48
Other Gand A
43.93
-24.06%
57.85
+9.38%
52.89
+16.28%
45.48
Total Expenses
150.67
-20.42%
189.33
-12.52%
216.41
+3.05%
210.00
Operating Income
-85.35
+29.86%
-121.69
+11.31%
-137.21
-10.79%
-123.84
Total Operating Income As Reported
-85.35
+29.86%
-121.69
+11.31%
-137.21
-10.79%
-123.84
EBITDA
-71.28
+31.80%
-104.51
+15.36%
-123.48
-3.57%
-119.22
Normalized EBITDA
-71.32
+31.81%
-104.58
+15.30%
-123.48
-3.50%
-119.30
Reconciled Depreciation
4.59
+96.32%
2.34
-1.48%
2.37
-20.25%
2.97
EBIT
-75.87
+28.99%
-106.85
+15.10%
-125.85
-2.99%
-122.19
Total Unusual Items
0.04
-46.58%
0.07
0.08
Total Unusual Items Excluding Goodwill
0.04
-46.58%
0.07
0.08
Net Income
-81.89
+29.43%
-116.05
+13.28%
-133.82
-9.91%
-121.75
Pretax Income
-83.55
+29.07%
-117.79
+10.08%
-131.00
-7.21%
-122.19
Net Non Operating Interest Income Expense
1.76
-54.02%
3.83
-38.35%
6.21
+294.91%
1.57
Interest Expense Non Operating
7.68
-29.79%
10.94
+112.51%
5.15
0.00
Net Interest Income
1.76
-54.02%
3.83
-38.35%
6.21
+294.91%
1.57
Interest Expense
7.68
-29.79%
10.94
+112.51%
5.15
0.00
Interest Income Non Operating
9.44
-36.07%
14.77
+30.02%
11.36
+622.19%
1.57
Interest Income
9.44
-36.07%
14.77
+30.02%
11.36
+622.19%
1.57
Other Income Expense
0.04
-46.58%
0.07
0.08
Other Non Operating Income Expenses
0.08
Gain On Sale Of Security
0.04
-46.58%
0.07
0.08
Tax Provision
-1.66
+4.76%
-1.74
-161.79%
2.82
+751.50%
-0.43
Tax Rate For Calcs
0.00
+33.33%
0.00
-92.86%
0.00
+5150.00%
0.00
Tax Effect Of Unusual Items
0.00
-28.77%
0.00
0.00
-100.00%
0.00
Net Income Including Noncontrolling Interests
-81.89
+29.43%
-116.05
+13.28%
-133.82
-9.91%
-121.75
Net Income From Continuing Operation Net Minority Interest
-81.89
+29.43%
-116.05
+13.28%
-133.82
-9.91%
-121.75
Net Income From Continuing And Discontinued Operation
-81.89
+29.43%
-116.05
+13.28%
-133.82
-9.91%
-121.75
Net Income Continuous Operations
-81.89
+29.43%
-116.05
+13.28%
-133.82
-9.91%
-121.75
Normalized Income
-81.93
+29.44%
-116.12
+13.23%
-133.82
-9.83%
-121.84
Net Income Common Stockholders
-81.89
+29.43%
-116.05
+13.28%
-133.82
-9.91%
-121.75
Diluted EPS
-3.84
+29.93%
-5.48
+14.11%
-6.38
-7.95%
-5.91
Basic EPS
-3.84
+29.93%
-5.48
+14.11%
-6.38
-7.95%
-5.91
Basic Average Shares
21.34
+0.85%
21.16
+0.90%
20.97
+1.78%
20.60
Diluted Average Shares
21.34
+0.85%
21.16
+0.90%
20.97
+1.78%
20.60
Diluted NI Availto Com Stockholders
-81.89
+29.43%
-116.05
+13.28%
-133.82
-9.91%
-121.75
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Assets
280.73
-25.47%
376.65
-18.52%
462.27
+23.14%
375.41
Current Assets
204.34
-31.85%
299.85
-29.08%
422.79
+35.63%
311.71
Cash Cash Equivalents And Short Term Investments
188.86
-23.90%
248.19
-32.91%
369.91
+48.42%
249.23
Cash And Cash Equivalents
32.30
-13.25%
37.23
-56.40%
85.39
+94.09%
43.99
Other Short Term Investments
156.57
-25.78%
210.95
-25.86%
284.52
+38.63%
205.24
Receivables
6.88
-82.19%
38.65
-2.46%
39.62
-19.21%
49.04
Accounts Receivable
6.88
+3.55%
6.65
-22.85%
8.61
-57.60%
20.32
Taxes Receivable
0.00
-100.00%
32.00
+3.21%
31.00
+7.96%
28.72
Prepaid Assets
13.45
Restricted Cash
0.00
-100.00%
0.61
0.00
Other Current Assets
8.59
-30.80%
12.41
-6.41%
13.26
-1.35%
13.45
Total Non Current Assets
76.40
-0.53%
76.80
+94.51%
39.48
-38.01%
63.70
Net PPE
72.94
-0.55%
73.35
+111.29%
34.71
+16.69%
29.75
Gross PPE
96.75
-1.67%
98.39
+68.31%
58.46
+13.28%
51.61
Accumulated Depreciation
-23.80
+4.96%
-25.05
-5.48%
-23.75
-8.63%
-21.86
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
21.00
-0.06%
21.01
+2.06%
20.59
+13.12%
18.20
Construction In Progress
0.00
-100.00%
22.75
+1686.96%
1.27
-50.20%
2.56
Other Properties
37.55
-7.65%
40.66
+78.37%
22.79
-3.31%
23.57
Leases
38.20
+173.35%
13.97
+1.24%
13.80
+89.72%
7.28
Investments And Advances
0.00
-100.00%
29.29
Other Non Current Assets
3.45
-0.06%
3.45
-27.60%
4.77
+2.29%
4.66
Total Liabilities Net Minority Interest
216.01
-12.84%
247.84
+0.94%
245.54
+354.06%
54.08
Current Liabilities
48.55
-15.61%
57.53
-8.36%
62.79
+110.50%
29.83
Payables And Accrued Expenses
14.70
-31.79%
21.55
-3.95%
22.44
-16.71%
26.94
Payables
1.95
-75.66%
8.00
+95.31%
4.10
-31.72%
6.00
Accounts Payable
1.95
-75.66%
8.00
+95.31%
4.10
-31.72%
6.00
Current Accrued Expenses
12.75
-5.88%
13.55
-26.13%
18.34
-12.40%
20.94
Current Debt And Capital Lease Obligation
3.15
+106.43%
1.52
-71.11%
5.28
+82.46%
2.89
Current Capital Lease Obligation
3.15
+106.43%
1.52
-71.11%
5.28
+82.46%
2.89
Other Current Liabilities
30.71
-10.89%
34.46
-1.75%
35.08
Total Non Current Liabilities Net Minority Interest
167.46
-12.00%
190.30
+4.13%
182.75
+653.65%
24.25
Long Term Debt And Capital Lease Obligation
54.76
+1.51%
53.94
+153.99%
21.24
-5.07%
22.37
Long Term Capital Lease Obligation
54.76
+1.51%
53.94
+153.99%
21.24
-5.07%
22.37
Other Non Current Liabilities
111.39
-17.49%
135.01
-15.67%
160.09
+35162.56%
0.45
Preferred Securities Outside Stock Equity
1.31
-2.89%
1.35
-5.13%
1.42
+0.00%
1.42
Stockholders Equity
64.72
-49.76%
128.81
-40.57%
216.74
-32.55%
321.33
Common Stock Equity
64.72
-49.76%
128.81
-40.57%
216.74
-32.55%
321.33
Capital Stock
0.21
+0.94%
0.21
+0.47%
0.21
+1.44%
0.21
Common Stock
0.21
+0.94%
0.21
+0.47%
0.21
+1.44%
0.21
Share Issued
21.39
+0.91%
21.19
+0.64%
21.06
+1.29%
20.79
Ordinary Shares Number
21.39
+0.91%
21.19
+0.64%
21.06
+1.29%
20.79
Additional Paid In Capital
469.77
+4.08%
451.34
+6.27%
424.69
+6.70%
398.03
Retained Earnings
-404.93
-25.35%
-323.04
-56.06%
-207.00
-182.86%
-73.18
Gains Losses Not Affecting Retained Earnings
-0.34
-212.25%
0.30
+125.72%
-1.17
+68.47%
-3.72
Other Equity Adjustments
-0.34
-212.25%
0.30
+125.72%
-1.17
+68.47%
-3.72
Total Equity Gross Minority Interest
64.72
-49.76%
128.81
-40.57%
216.74
-32.55%
321.33
Total Capitalization
64.72
-49.76%
128.81
-40.57%
216.74
-32.55%
321.33
Working Capital
155.78
-35.71%
242.32
-32.69%
360.00
+27.71%
281.89
Invested Capital
64.72
-49.76%
128.81
-40.57%
216.74
-32.55%
321.33
Total Debt
57.90
+4.39%
55.47
+109.21%
26.51
+4.95%
25.26
Capital Lease Obligations
57.90
+4.39%
55.47
+109.21%
26.51
+4.95%
25.26
Net Tangible Assets
64.72
-49.76%
128.81
-40.57%
216.74
-32.55%
321.33
Tangible Book Value
64.72
-49.76%
128.81
-40.57%
216.74
-32.55%
321.33
Available For Sale Securities
29.29
Investmentin Financial Assets
0.00
-100.00%
29.29
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
-19.27
+75.53%
-78.76
+23.64%
-103.15
-21.67%
-84.78
Cash Flow From Continuing Operating Activities
-19.27
+75.53%
-78.76
+23.64%
-103.15
-21.67%
-84.78
Net Income From Continuing Operations
-81.89
+29.43%
-116.05
+13.28%
-133.82
-9.91%
-121.75
Depreciation Amortization Depletion
4.59
+96.32%
2.34
-1.48%
2.37
-20.25%
2.97
Depreciation
4.59
Depreciation And Amortization
4.59
+96.32%
2.34
-1.48%
2.37
-20.25%
2.97
Other Non Cash Items
-0.95
-144.44%
2.14
+140.85%
-5.24
-464.37%
-0.93
Stock Based Compensation
18.57
-30.71%
26.80
-5.04%
28.22
+4.62%
26.97
Deferred Tax
0.00
0.00
Deferred Income Tax
0.00
0.00
Operating Gains Losses
0.01
-62.50%
0.02
-89.33%
0.15
Gain Loss On Investment Securities
Gain Loss On Sale Of PPE
0.01
-62.50%
0.02
-89.33%
0.15
0.00
Change In Working Capital
39.91
+459.73%
7.13
-11.14%
8.02
+18.19%
6.79
Change In Receivables
31.76
+3164.44%
0.97
-89.67%
9.42
-20.15%
11.79
Changes In Account Receivables
-0.24
-111.99%
1.97
-83.19%
11.70
+259.24%
3.26
Change In Prepaid Assets
3.82
+349.76%
0.85
+367.03%
0.18
-75.50%
0.74
Change In Payables And Accrued Expense
-1.25
+79.32%
-6.06
-63.39%
-3.71
+39.31%
-6.11
Change In Accrued Expense
0.06
+101.03%
-5.65
-120.72%
-2.56
-73.19%
-1.48
Change In Payable
-1.31
-216.67%
-0.41
+64.03%
-1.15
+75.16%
-4.63
Change In Account Payable
-1.31
-216.67%
-0.41
+64.03%
-1.15
+75.16%
-4.63
Change In Other Working Capital
-0.60
Change In Other Current Assets
4.31
-36.66%
6.80
+51.53%
4.49
+7.65%
4.17
Change In Other Current Liabilities
1.27
-72.25%
4.56
+293.47%
-2.36
+38.11%
-3.81
Investing Cash Flow
40.35
-30.72%
58.23
+208.69%
-53.58
-197.60%
54.90
Cash Flow From Continuing Investing Activities
40.35
-30.72%
58.23
+208.69%
-53.58
-197.60%
54.90
Net PPE Purchase And Sale
-12.90
+28.15%
-17.95
-98.15%
-9.06
-326.26%
-2.12
Purchase Of PPE
-12.90
+28.15%
-17.95
-98.15%
-9.06
-326.26%
-2.12
Capital Expenditure
-12.90
+28.15%
-17.95
-98.15%
-9.06
-326.26%
-2.12
Net Investment Purchase And Sale
53.24
-30.11%
76.18
+271.12%
-44.52
-178.08%
57.02
Purchase Of Investment
-209.63
+31.78%
-307.28
+17.71%
-373.39
-117.79%
-171.45
Sale Of Investment
262.87
-31.45%
383.46
+16.60%
328.87
+43.95%
228.47
Financing Cash Flow
-26.62
+3.65%
-27.63
-113.94%
198.13
+889.00%
20.03
Cash Flow From Continuing Financing Activities
-26.62
+3.65%
-27.63
-113.94%
198.13
+889.00%
20.03
Net Issuance Payments Of Debt
-27.48
0.00
0.00
Repayment Of Debt
-27.48
0.00
0.00
Long Term Debt Payments
-27.48
0.00
0.00
Net Long Term Debt Issuance
-27.48
0.00
0.00
Proceeds From Stock Option Exercised
0.14
-1.36%
0.15
-93.34%
2.21
-89.62%
21.26
Net Other Financing Charges
-26.76
+3.64%
-27.77
-114.18%
195.92
+16041.25%
-1.23
Changes In Cash
-5.54
+88.49%
-48.16
-216.33%
41.39
+520.16%
-9.85
Beginning Cash Position
41.20
-53.89%
89.36
+86.31%
47.96
-17.04%
57.81
End Cash Position
35.66
-13.45%
41.20
-53.89%
89.36
+86.31%
47.96
Free Cash Flow
-32.17
+66.74%
-96.71
+13.81%
-112.21
-29.12%
-86.91
Interest Paid Supplemental Data
8.79
-24.90%
11.71
+489.33%
1.99
0.00
Income Tax Paid Supplemental Data
0.11
-54.77%
0.24
-95.08%
4.90
0.00
Amortization Of Securities
0.50
+144.20%
-1.14
+60.15%
-2.86
-343.89%
1.17
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category